• Proteon Therapeutics to merge with ArTara Therapeutics pharmaceutical-technology
    September 25, 2019
    Proteon Therapeutics, which focuses on kidney and vascular diseases, has signed a definitive agreement to merge with rare and speciality disease drugs developer ArTara Therapeutics.
PharmaSources Customer Service